Xiaojuan Wei
Impact in
- Biomaterials top 5%
- Electrospun Nanofibers in Biomedical Applications
- Rehabilitation top 5%
Papers in
-
- Electrospun Nanofibers in Biomedical Applications 7
-
- MicroRNA in disease regulation 3
- Co-authors
- Jing Liu (1 shared paper)Changqing Zhang (15 shared papers)Yang Yang (1 shared paper)Zhenzhong Zhu (9 shared papers)Qian Tang (7 shared papers)Zi‐Kuan Guo (4 shared papers)Wei Wang (2 shared papers)Liyan Shen (2 shared papers)
- Journals
- Bioactive Materials (3 papers)Biomaterials (3 papers)Carbohydrate Polymers (1 paper)Aging (1 paper)Medicinal Chemistry Research (1 paper)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xiaojuan Wei
61 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 120
- Biomaterials 262
- Rehabilitation 85
- Molecular Medicine 63
- Cancer Research 133
- Biomedical Engineering 416
Countries citing papers authored by Xiaojuan Wei
This map shows the geographic impact of Xiaojuan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojuan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojuan Wei more than expected).
Fields of papers citing papers by Xiaojuan Wei
This network shows the impact of papers produced by Xiaojuan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojuan Wei. The network helps show where Xiaojuan Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojuan Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 154 | |
| 2 | 2007 | 143 | |
| 3 | 2019 | 134 | |
| 4 | 2016 | 85 | |
| 5 | 2022 | 62 | |
| 6 | 2020 | 61 | |
| 7 | 2010 | 59 | |
| 8 | 2020 | 53 | |
| 9 | 2021 | 51 | |
| 10 | 2008 | 46 | |
| 11 | 2012 | 44 | |
| 12 | 2021 | 44 | |
| 13 | 2019 | 44 | |
| 14 | 2020 | 41 | |
| 15 | 2014 | 41 | |
| 16 | 2011 | 39 | |
| 17 | 2022 | 34 | |
| 18 | 2016 | 32 | |
| 19 | Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages. | 2017 | 27 |
| 20 | 2021 | 27 |
About Xiaojuan Wei
Xiaojuan Wei is a scholar working on Biomaterials, Cancer Research, Urology, Molecular Biology and Rehabilitation, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (7 papers), Extracellular vesicles in disease (7 papers), Bone Tissue Engineering Materials (7 papers), Wound Healing and Treatments (4 papers), Tissue Engineering and Regenerative Medicine (4 papers), Periodontal Regeneration and Treatments (4 papers), MicroRNA in disease regulation (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Biomaterials (262 citations), Rehabilitation (85 citations), Molecular Medicine (63 citations), Cancer Research (133 citations) and Biomedical Engineering (416 citations). Xiaojuan Wei has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Jing Liu, Changqing Zhang, Yang Yang, Jing Liu, Zhenzhong Zhu, Qian Tang, Zi‐Kuan Guo, Wei Wang, Liyan Shen and Hongchao Zhang. Their work appears in journals such as Bioactive Materials, Biomaterials, Carbohydrate Polymers, Aging and Medicinal Chemistry Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.